Concepedia

Shashikant Nagre

SN

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2018

Affiliations

Akston Biosciences (United States)(Current)

Baylor College of Medicine

Texas Children's Hospital

University Medical Center Groningen

Pfizer (United States)

Shashikant Nagre is an author at Akston Biosciences (United States) specializing in vaccine immunology, vaccination, and vaccinology.

Publications per year

2018–2023

5

Publications

5

Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

David G. Alleva, Andrea R. Delpero, Melanie Scully et al. · Vaccine · 2021 · 45 citations · Full text

, , +17

Shift to high‐intensity, low‐volume perfusion cell culture enabling a continuous, integrated bioprocess

Matthew Gagnon, Shashikant Nagre, Wenge Wang et al. · Biotechnology Progress · 2018 · 42 citations

, , +16

Novel, linked bioreactor system for continuous production of biologics

Matthew Gagnon, Shashikant Nagre, Wenge Wang et al. · Biotechnology and Bioengineering · 2019 · 22 citations

, , +17

Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452

Yester F. Janssen, Eline A. Feitsma, Hendrikus H. Boersma et al. · Vaccine · 2022 · 17 citations · Full text

, , +17

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

Eline A. Feitsma, Yester F. Janssen, Hendrikus H. Boersma et al. · Vaccine · 2023 · 16 citations · Full text

, , +17

1–5 of 5